Marty Makary, MD, MPH, described the action as part of a new era, noting increased attention to misleading claims made by telehealth and pharmaceutical companies across media platforms
Effects of the switch from dulaglutide to tirzepatide on glycemic control, body weight, and fatty liver: a retrospective study
For years, people with type 2 diabetes have relied on a synthetic version of the hormone, called a GLP-1 agonist, to help them manage their symptoms and maintain normal blood sugar levels
Effect of ertugliflozin on blood pressure in patients with type 2 diabetes mellitus: a post hoc pooled analysis of randomized controlled trials
Reimann F
Spoiler alert: the answer is a little more personalized than a one-size-fits-all clock-in time